Dr. Phillip J. Goldstein, MD

Dr. Goldstein practices at Carolina Digestive Diseases Endoscopy Center in Greenville, North Carolina.

Dr. Goldstein's NPI, 1346406147, was assigned on July 31, 2008. Dr. Goldstein holds North Carolina license 2009-02033.

Dr. Goldstein's primary practice is Carolina Digestive Diseases Endoscopy Center, at 704 Wh Smith Blvd, Greenville, NC 27834. The practice phone is (252) 758-8181.

Dr. Goldstein's primary practice is Carolina Digestive Diseases Endoscopy Center in Greenville, North Carolina. Dr. Goldstein is also affiliated with ECU Health Medical Center. The medical group on file is Carolina Digestive Diseases. Dmand AI also links Dr. Goldstein to 2 more hospitals, each named with a free account. Dr. Goldstein's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldstein practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Goldstein's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Goldstein's licenses on file in 2 states: North Carolina and New York.

CMS data shows 2,478 Medicare services from Dr. Goldstein across 15 procedure codes in 2024, for 799 Medicare patients. Medicare paid $204,627 for them.

CMS counts 799 Medicare patients who saw Dr. Goldstein in 2024. The largest group is 65 to 74, with 379 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goldstein's median patient age at 66, with 59% women.

In 2024, Dr. Goldstein wrote 6,501 Medicare Part D claims for 1,520 patients. 79% of them were for generic drugs. CMS names the drug for 6,274 of them, across 59 drugs with 11 or more claims each, at $3,668,063 in total drug cost. In 2023, CMS named 5,949 claims across 64 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Goldstein for performance year 2024, reported as part of a group. Dr. Goldstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 241 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Goldstein, more than 93% of the clinicians it reports for that procedure.

Dmand AI links Dr. Goldstein to 6 clinical trials. 2 are still active or recruiting. Conditions studied include Colitis, Ulcerative, Colitis and Crohn Disease. Eli Lilly and Company sponsors the most, 5. Open Payments lists research payments to Dr. Goldstein that name 5 trials.

CMS Open Payments shows 1,456 general payments to Dr. Goldstein from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Abbvie Inc. paid the most, $6,277. It also lists 11 research payments totaling $20,667 from 2016 to 2021, naming 5 clinical trials.